301. Usability and Acceptability of a Web-Based Program for Chemotherapy-Induced Peripheral Neuropathy.
- Author
-
Tofthagen C, Kip KE, Passmore D, Loy I, and Berry DL
- Subjects
- Aged, Antineoplastic Agents administration & dosage, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Male, Middle Aged, Neoplasms drug therapy, Self Care, Surveys and Questionnaires, Antineoplastic Agents adverse effects, Internet, Patient Education as Topic, Peripheral Nervous System Diseases chemically induced
- Abstract
Chemotherapy-induced neuropathy is a painful and debilitating adverse effect of certain chemotherapy drugs. There have not been any patient-centered, easily accessible Web-based interventions to assist with self-management of chemotherapy-induced neuropathy. The aims of this study were to evaluate usability and acceptability and to estimate an effect size of a Web-based intervention for assessing and managing chemotherapy-induced neuropathy. Participants (N = 14) were instructed to complete the Creativity, Optimism, Planning, and Expert Information for Chemotherapy-Induced Peripheral Neuropathy program and provide verbal responses to the program. Participants completed the Chemotherapy Induced Peripheral Neuropathy Assessment Tool and Post-Study System Usability Questionnaire. Iterative changes were made to the COPE-CIPN. Participants were asked to provide feedback on the revised COPE-CIPN, repeat the Chemotherapy Induced Peripheral Neuropathy Assessment Tool, and evaluate acceptability using the Acceptability e-Scale. The COPE-CIPN demonstrated high usability (mean, 1.98 [SD, 1.12]) and acceptability (mean, 4.40 [SD, 0.52]). Comments indicated that the interface was easy to use, and the information was helpful. While neuropathy symptoms continued to increase in this group of patients receiving neurotoxic chemotherapy, there was a decrease in mean level of interference with activities from 53.71 to 39.29 over 3 to 4 months, which indicated a moderate effect (d = 0.39) size. The COPE-CIPN may be a useful intervention to support self-management of chemotherapy-induced neuropathy.
- Published
- 2016
- Full Text
- View/download PDF